WO2003033695A1 - Procede de purification de proteine fusionnee recombinee et procede de production de proteine utilisant ledit procede de purification - Google Patents

Procede de purification de proteine fusionnee recombinee et procede de production de proteine utilisant ledit procede de purification Download PDF

Info

Publication number
WO2003033695A1
WO2003033695A1 PCT/JP2002/010578 JP0210578W WO03033695A1 WO 2003033695 A1 WO2003033695 A1 WO 2003033695A1 JP 0210578 W JP0210578 W JP 0210578W WO 03033695 A1 WO03033695 A1 WO 03033695A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
recombinant fused
dockerin
fused protein
target protein
Prior art date
Application number
PCT/JP2002/010578
Other languages
English (en)
French (fr)
Inventor
Tsuyoshi Nomura
Hidekazu Nagaya
Akio Shimamura
Shinichi Naya
Toshimichi Kanaya
Kazuo Sakka
Kunio Ohmiya
Original Assignee
Katakura Industries Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katakura Industries Co., Ltd. filed Critical Katakura Industries Co., Ltd.
Priority to JP2003536422A priority Critical patent/JPWO2003033695A1/ja
Priority to EP02801543A priority patent/EP1441030A4/en
Priority to US10/490,737 priority patent/US20050106700A1/en
Publication of WO2003033695A1 publication Critical patent/WO2003033695A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PCT/JP2002/010578 2001-10-11 2002-10-11 Procede de purification de proteine fusionnee recombinee et procede de production de proteine utilisant ledit procede de purification WO2003033695A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2003536422A JPWO2003033695A1 (ja) 2001-10-11 2002-10-11 組換え融合タンパク質の精製方法およびこれを利用するタンパク質の製造方法
EP02801543A EP1441030A4 (en) 2001-10-11 2002-10-11 METHOD OF PURIFYING RECOMBINANT FUSED PROTEIN AND PROTEIN PRODUCTION PROCESS USING THE PURIFICATION PROCESS
US10/490,737 US20050106700A1 (en) 2001-10-11 2002-10-11 Method of purifying recombinant fused protein and method of producing protein using the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001314079 2001-10-11
JP2001-314079 2001-10-11

Publications (1)

Publication Number Publication Date
WO2003033695A1 true WO2003033695A1 (fr) 2003-04-24

Family

ID=19132446

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/010578 WO2003033695A1 (fr) 2001-10-11 2002-10-11 Procede de purification de proteine fusionnee recombinee et procede de production de proteine utilisant ledit procede de purification

Country Status (4)

Country Link
US (1) US20050106700A1 (ja)
EP (1) EP1441030A4 (ja)
JP (1) JPWO2003033695A1 (ja)
WO (1) WO2003033695A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009028531A1 (ja) * 2007-08-27 2009-03-05 Katakura Industries Co., Ltd. ドックリンポリペプチドおよびそれを利用した組換え融合タンパク質の精製方法
JP2010518020A (ja) * 2007-02-02 2010-05-27 ベイラー リサーチ インスティテュート ヒト化ターゲティングモノクローナル抗体と複合体を形成する複数の可変抗原
JP2011528233A (ja) * 2008-07-16 2011-11-17 ベイラー リサーチ インスティテュート 最大限のｇａｇ及びｎｅｆを樹状細胞に対して標的化することに基づくｈｉｖワクチン
CN104844685A (zh) * 2015-06-12 2015-08-19 中国科学院植物研究所 一种变性抗原亲和纯化抗体方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5377330B2 (ja) 2007-02-02 2013-12-25 ベイラー リサーチ インスティテュート 抗原提示細胞上に発現されたｄｃｉｒへの抗原のターゲティングに基づくワクチン
TWI422594B (zh) 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
NZ579262A (en) * 2007-02-23 2012-04-27 Baylor Res Inst Therapeutic applications of activation of human antigen-presenting cells through dectin-1
EP2307443B1 (en) * 2008-08-07 2013-10-02 Yeda Research And Development Company Ltd. Affinity purification by cohesin-dockerin interaction
CN103045627B (zh) * 2012-11-09 2015-04-15 逢甲大学 于细胞内制造蛋白复合物的方法
CA3185180A1 (en) 2014-05-16 2015-11-19 Baylor Research Institute Methods and compositions for treating autoimmune and inflammatory conditions
US11000597B2 (en) 2015-01-21 2021-05-11 University Of Florida Research Foundation, Incorporated Engineered receptor/ligand system for delivery of therapeutic agents
AU2018224044B2 (en) 2017-02-21 2024-01-25 The Uab Research Foundation Modified AAV capsid proteins and uses thereof
CN111518851B (zh) * 2019-11-06 2023-05-23 上海健康医学院 一种固定化酶连续制备[14/15n]-l-瓜氨酸的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016083A1 (en) * 1993-01-15 1994-07-21 Genetics Institute, Inc. Cloning of enterokinase and method of use
JP2000157282A (ja) * 1998-11-30 2000-06-13 Toyota Central Res & Dev Lab Inc 酵素配列複合体及び固定化酵素配列複合体とそれらの製造方法、担体分子及び酵素

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0859835A2 (en) * 1995-10-17 1998-08-26 Genencor International, Inc. Enzymatic array and process of making same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016083A1 (en) * 1993-01-15 1994-07-21 Genetics Institute, Inc. Cloning of enterokinase and method of use
JP2000157282A (ja) * 1998-11-30 2000-06-13 Toyota Central Res & Dev Lab Inc 酵素配列複合体及び固定化酵素配列複合体とそれらの製造方法、担体分子及び酵素

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
KAKIUCHI M. ET AL.: "Cloning and DNA sequencing of the genes encoding Clostridium josui scaffoloding protein CipA and cellulase CelD and identification of their gene products as major components of the cellulosome", JOURNAL OF BACTERIOLOGY, vol. 180, no. 16, August 1998 (1998-08-01), pages 4303 - 4308, XP002966853 *
PAGES S. ET AL.: "Interaction between the endoglucanase CelA and the scaffolding protein CipC of the Clostridium cellulolyticum cellulosome", JOURNAL OF BACTERIOLOGY, vol. 178, no. 8, April 1996 (1996-04-01), pages 2279 - 2286, XP002966851 *
PARK J.S. ET AL.: "Cohesin-dockerin interactions of cellulosomal subunits of Clostridium cellulovorans", JOURNAL OF BACTERIOLOGY, vol. 183, no. 18, September 2001 (2001-09-01), pages 5431 - 5435, XP002966852 *
See also references of EP1441030A4 *
STOFKO-HAHN R.E. ET AL.: "A single step purification for recombinant proteins characterization of a microtuble associated protein (MAP2) fragment which associates with the type II cAMP-dependent protein kinase", FEBS LETTERS, vol. 302, no. 3, May 1992 (1992-05-01), pages 274 - 278, XP000267798 *
TAVARES G.A. ET AL.: "The crystal structure of a type I cohesin domain at 1.7 a resolution", JOURNAL OF MOLECULAR BIOLOGY, vol. 273, no. 3, October 1997 (1997-10-01), pages 701 - 713, XP002966850 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010518020A (ja) * 2007-02-02 2010-05-27 ベイラー リサーチ インスティテュート ヒト化ターゲティングモノクローナル抗体と複合体を形成する複数の可変抗原
WO2009028531A1 (ja) * 2007-08-27 2009-03-05 Katakura Industries Co., Ltd. ドックリンポリペプチドおよびそれを利用した組換え融合タンパク質の精製方法
US8536302B2 (en) 2007-08-27 2013-09-17 Sysmex Corporation Dockerin polypeptide and method of purifying recombinant fused protein using the same
JP5307716B2 (ja) * 2007-08-27 2013-10-02 シスメックス株式会社 ドックリンポリペプチドおよびそれを利用した組換え融合タンパク質の精製方法
JP2011528233A (ja) * 2008-07-16 2011-11-17 ベイラー リサーチ インスティテュート 最大限のｇａｇ及びｎｅｆを樹状細胞に対して標的化することに基づくｈｉｖワクチン
JP2015071598A (ja) * 2008-07-16 2015-04-16 ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ 最大限のｇａｇ及びｎｅｆを樹状細胞に対して標的化することに基づくｈｉｖワクチン
US9109011B2 (en) 2008-07-16 2015-08-18 Baylor Research Institute Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef
CN104844685A (zh) * 2015-06-12 2015-08-19 中国科学院植物研究所 一种变性抗原亲和纯化抗体方法
CN104844685B (zh) * 2015-06-12 2018-10-16 中国科学院植物研究所 一种变性抗原亲和纯化抗体方法

Also Published As

Publication number Publication date
EP1441030A1 (en) 2004-07-28
US20050106700A1 (en) 2005-05-19
JPWO2003033695A1 (ja) 2005-02-03
EP1441030A4 (en) 2007-08-15

Similar Documents

Publication Publication Date Title
WO2003033695A1 (fr) Procede de purification de proteine fusionnee recombinee et procede de production de proteine utilisant ledit procede de purification
ATE301187T1 (de) Plastidtransformation in arabidopsis thaliana
WO2003000840A3 (en) Nitrilases
PL356771A1 (en) Magnetic glass particles, method for their preparation and uses thereof
WO2000040615A3 (en) EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
PL352332A1 (en) Expression and export of interferon-alpha proteins as fc fusion proteins
WO2001029242A3 (en) Post-translational modification of recombinant proteins produced in plants
WO2002000711A3 (en) Ev-vegf nucleic acids and polypeptides and methods of use
WO2000011033A3 (en) Expression and export of angiostatin and endostatin as immunofusins
WO2000023593A3 (en) Molecular pathogenicide mediated plant disease resistance
GB0129105D0 (en) Expression control using variable intergenic sequences
DK1106696T3 (da) Proteindeamiderende enzym, mikroorganisme producerende dette, gen kodende derfor, fremgangsmåde til fremstilling af enzymet og anvendelse deraf
WO2000006717A3 (en) Improved transformation efficiency in phage display through modification of a coat protein
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
WO2006018650A3 (en) Method of in vitro polypeptide selection using the arc dna binding domain fused to the polypeptide to be selected
WO2001066778A3 (en) Production of foreign polypeptides in plants as viral coat protein fusions
WO2003076561A3 (en) Recombinase fusion protein with enhanced cellular uptake
ATE417056T1 (de) Verfahren zur proteinreinigung
WO2003089569A3 (en) Use of il-19, il-22 and il-24 to treat hematopoietic disorders
WO2002016611A3 (en) Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
DE69835813D1 (de) Verfahren zur kultivierung von zellen und zur vermehrung von viren
EP1358318B8 (en) Hybridoma cell line g250 and its use for producing monoclonal antibodies
EP1870454A4 (en) PROCESS FOR DIPEPTIDE PRODUCTION
WO2001083754A3 (en) Cellular regulators of infectious agents and methods of use
WO2002088338A3 (fr) Procede de replication du virus de l'hepatite c

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003536422

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002801543

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10490737

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002801543

Country of ref document: EP